IP Library Granted Patent US 11,746,339
Granted Patent B2
US 11,746,339 · App. 17/199,343 · Granted Sep 5, 2023

Modified DNA polymerases for improved amplification

Inventors: Wolfgang Schafer (Western Cape, ZA); Paul J. McEwan (Diablo, CA); Eric van der Walt (Western Cape, ZA); John Foskett (Boulder, CO); William Bourn (Western Cape, CA)
Assignee: Kapa Biosystems, Inc.
C12N9/1252C12P19/34C12Q1/686C12Y207/07007Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,746,339
App. No.
17/199,343
Granted
Sep 5, 2023
Kind
B2
Abstract

The present invention provides improved DNA polymerases that may be better suited for applications in recombinant DNA technologies, in particular technologies involving plant-derived samples. Among other things, the present invention provides modified DNA polymerases derived from directed evolution experiments designed to select mutations that confer advantageous phenotypes under conditions used in industrial or research applications.

Claims (15)

1. A kit comprising:

(i) a package unit with a container comprising a modified Taq DNA polymerase whose amino acid sequence shares at least 95% identity with that of SEQ ID NO: 48, including in that it has L at a position corresponding to F749 of a reference Taq DNA polymerase of SEQ ID NO: 38, and in that it has at least two other amino acid substitutions at positions relative SEQ ID NO: 38, which substitutions are selected from the group consisting of T at 61, E at 346, C at 357, K at 507, M at 707 and combinations thereof; and

(ii) instructions.

2. A kit comprising:

(i) a package unit with a container comprising a modified Taq DNA polymerase having the amino acid sequence of SEQ ID NO: 47 or SEQ ID NO: 48; and

(ii) instructions.

3. The kit of claim 2 , wherein the modified Taq DNA polymerase has the amino acid sequence of SEQ ID NO: 47.

4. The kit of claim 2 , wherein the modified Taq DNA polymerase has the amino acid sequence of SEQ ID NO: 48.

5. The kit of claim 1 , wherein the modified Taq DNA polymerase has increased resistance to a plant-derived PCR inhibitor as compared to that of SEQ ID NO: 38.

6. The kit of claim 1 , wherein the modified Taq DNA polymerase has an amino acid sequence that shares 96% identity with that of SEQ ID NO: 48.

7. The kit of claim 1 , wherein the modified Taq DNA polymerase has an amino acid sequence that shares 97% identity with that of SEQ ID NO: 48.

8. The kit of claim 1 , wherein the modified Taq DNA polymerase has an amino acid sequence that shares 98% identity with that of SEQ ID NO: 48.

9. The kit of claim 1 comprising a vector comprising a polynucleotide encoding the modified Taq DNA polymerase.

10. The kit of claim 1 comprising a cell comprising a polynucleotide encoding the modified Taq DNA polymerase.

11. The kit of claim 1 comprising a cell comprising a vector comprising a polynucleotide encoding the modified Taq DNA polymerase.

Assignments (2)
CONFIRMATORY ASSIGNMENT Recorded Feb 23, 2023
From: KAPA BIOSYSTEMS
To: KAPA BIOSYSTEMS, INC.
Reel/Frame 062848/0793 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2021
From: SCHAFER, WOLFGANG; MCEWAN, PAUL; VAN DER WALT, ERIC; FOSKETT, JOHN; BOURN, WILLIAM
To: KAPA BIOSYSTEMS
Reel/Frame 055667/0746 →
Continuity (4)
Continuation 15130339 · Apr 15, 2016
Continuation 13979509
Provisional Application 61432936 · Jan 14, 2011
Related Publication 20210317422A1 · Oct 14, 2021